MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a highly chemoresistant tumor entity for which no reliable molecular targets exist to predict or influence the success of chemotherapy. Recently, we identified a panel of microRNAs associated with induced gemcitabine chemoresistance in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhayat, Sameer Abdallah, Abdeen, Baha, Köhler, Gabriele, Senninger, Norbert, Haier, Jörg, Mardin, Wolf Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690288/
https://www.ncbi.nlm.nih.gov/pubmed/26705427
http://dx.doi.org/10.1186/s13148-015-0166-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690288/
https://www.ncbi.nlm.nih.gov/pubmed/26705427
http://dx.doi.org/10.1186/s13148-015-0166-1

Ejemplares similares